Euglena International Network (EIN): Driving euglenoids into the biotechnology world

Abstract

Abstract teaserEuglenoids show great promise to benefit our world; as biofuels, environmental remediators, anti-cancer agents, robotics design simulators and food nutritional agents, but the absence of reference genomes currently limit realizing these benefits. The Euglena International Network (EIN) (https://euglenanetwork.org/) aims to address these challenges, and is currently seeking formative phase support and funding.Body startOf the nearly 1000 known species of euglenoids (Triemer and Zakryś, 2015), including Euglena gracilis and Rhabdomonas costata, fewer than 2 % have been explored for any level of translational potential in the past 20 years. The absence of reference genomes currently limits biotechnology applications, including the development of efficient tools for genetic manipulation in euglenoids.EIN aims to advance euglenoid science through a creative amalgam of academic institutions, national research institutes and biotechnology industry, to translate and exploit euglenoids through genome sequencing. EIN has defined goals, mobilized scientists, established a clear roadmap (Grand Challenges), connected academic and industry professionals and is currently formulating policy and partnership principles, driven by EIN Executive and Science committees. However, for EIN’s activities to be maintained and durable, long-term support is vital. We call on national and continental funding agencies and research councils, protists and algae communities, and biotechnology and pharmaceutical industries, to embrace, support and fund translational exploitation of these highly valuable organisms.